Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David-Axel Laplaud

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Revue Neurologique|November 24, 2019
Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirementRégis Bordet, William Camu, Jérôme De Seze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2021
Cumulative effects of therapies on disability in relapsing multiple sclerosisFabien Rollot, Romain Casey, Emmanuelle Leray, et al.
Clinical Immunology (Orlando, Fla.)|June 22, 2012
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patientsAnnie Elong Ngono, Ségolène Pettré, Marion Salou, et al.
Statistics in Medicine|December 12, 2022
Semi-supervised clustering of quaternion time series: Application to gait analysis in multiple sclerosis using motion sensor dataPierre Drouin, Aymeric Stamm, Laurent Chevreuil, et al.
European Journal of Immunology|April 27, 2026
Human Blood IgA<sup>+</sup> Memory B Cells Differ From IgG<sup>+</sup> B Cells by Expressing Gut-Homing and Regulatory MarkersLouise Le Gal, Léo Boussamet, Alexandra Garcia, et al.
The Journal of Clinical Investigation|September 5, 2008
Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysisLaure Michel, Laureline Berthelot, Ségolène Pettré, et al.
Clinical Immunology (Orlando, Fla.)|February 2, 2010
Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patientsLaureline Berthelot, Patrick Miqueu, Ségolène Pettré, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2019
High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practiceLaura Couloume, Laetitia Barbin, Emmanuelle Leray, et al.
Clinical Immunology (Orlando, Fla.)|November 4, 2008
Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cellsMonica Montes, Xin Zhang, Laureline Berthelot, et al.
Clinical Immunology (Orlando, Fla.)|March 21, 2022
Corrigendum to "Oligoclonal myelin-reactive T-cell infiltrates derived from neuromyelitis optica spectrum disorder (NMOSD) lesions are enriched in Th17 cells" [Clinical Immunology 130 (2009) 133-144]Monica Montes, Xin Zhang, Laureline Berthelot, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Revue Neurologique|November 24, 2019
Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirementRégis Bordet, William Camu, Jérôme De Seze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2021
Cumulative effects of therapies on disability in relapsing multiple sclerosisFabien Rollot, Romain Casey, Emmanuelle Leray, et al.
Clinical Immunology (Orlando, Fla.)|June 22, 2012
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patientsAnnie Elong Ngono, Ségolène Pettré, Marion Salou, et al.
Statistics in Medicine|December 12, 2022
Semi-supervised clustering of quaternion time series: Application to gait analysis in multiple sclerosis using motion sensor dataPierre Drouin, Aymeric Stamm, Laurent Chevreuil, et al.
European Journal of Immunology|April 27, 2026
Human Blood IgA<sup>+</sup> Memory B Cells Differ From IgG<sup>+</sup> B Cells by Expressing Gut-Homing and Regulatory MarkersLouise Le Gal, Léo Boussamet, Alexandra Garcia, et al.
The Journal of Clinical Investigation|September 5, 2008
Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysisLaure Michel, Laureline Berthelot, Ségolène Pettré, et al.
Clinical Immunology (Orlando, Fla.)|February 2, 2010
Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patientsLaureline Berthelot, Patrick Miqueu, Ségolène Pettré, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2019
High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practiceLaura Couloume, Laetitia Barbin, Emmanuelle Leray, et al.
Clinical Immunology (Orlando, Fla.)|November 4, 2008
Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cellsMonica Montes, Xin Zhang, Laureline Berthelot, et al.
Clinical Immunology (Orlando, Fla.)|March 21, 2022
Corrigendum to "Oligoclonal myelin-reactive T-cell infiltrates derived from neuromyelitis optica spectrum disorder (NMOSD) lesions are enriched in Th17 cells" [Clinical Immunology 130 (2009) 133-144]Monica Montes, Xin Zhang, Laureline Berthelot, et al.
Pageof 10